Most-Read Full-Text Articles http://www.jcp.sagepub.com/ Most-Read Full-Text Articles 2008-08-02 <![CDATA[PhRMA White Paper on ADME Pharmacogenomics]]> http://www.jcp.sagepub.com/cgi/content/short/48/7/849?rss=1&ssource=mfc Jul 1, 2008; 48:849-889
Pharmacogenomics]]> J. Andrew Williams, Tommy Andersson, Tommy B. Andersson, Rebecca Blanchard, Martin Otto Behm, Nadine Cohen, Timi Edeki, Monique Franc, Kathleen M. Hillgren, Keith J. Johnson, David A. Katz, Mark N. Milton, Bernard P. Murray, Joseph W. Polli, Deb Ricci, Lisa A. Shipley, Subrahmanyam Vangala, Steven A. Wrighton 2008-07-01 SAGE Publications <![CDATA[New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process]]> http://www.jcp.sagepub.com/cgi/content/short/48/6/662?rss=1&ssource=mfc Jun 1, 2008; 48:662-670
Drug Interactions/Review]]> Shiew-Mei Huang, John M. Strong, Lei Zhang, Kellie S. Reynolds, Srikanth Nallani, Robert Temple, Sophia Abraham, Sayed Al Habet, Raman K. Baweja, Gilbert J. Burckart, Sang Chung, Philip Colangelo, David Frucht, Martin D. Green, Paul Hepp, Elena Karnaukhova, Hon-Sum Ko, Jang-Ik Lee, Patrick J. Marroum, Janet M. Norden, Wei Qiu, Atiqur Rahman, Solomon Sobel, Toni Stifano, Kenneth Thummel, Xiao-xiong Wei, Sally Yasuda, Jenny H. Zheng, Hong Zhao, Lawrence J. Lesko 2008-06-01 SAGE Publications <![CDATA[Effects of Ibuprofen on the Magnitude and Duration of Aspirin's Inhibition of Platelet Aggregation: Clinical Consequences in Stroke Prophylaxis]]> http://www.jcp.sagepub.com/cgi/content/short/48/1/117?rss=1&ssource=mfc Jan 1, 2008; 48:117-122
Clinical Studies]]> Francis M. Gengo, Lisa Rubin, Matthew Robson, Michelle Rainka, Michael F. Gengo, Donald E. Mager, Vernice Bates 2008-01-01 10.1177/0091270007310379 SAGE Publications <![CDATA[An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/10?rss=1&ssource=mfc Jan 1, 2006; 46:10-20
Therapeutic Review]]> Amita Joshi, Robert Bauer, Peter Kuebler, Mark White, Cecelia Leddy, Peter Compton, Marvin Garovoy, Paul Kwon, Patricia Walicke, Russell Dedrick 2006-01-01 10.1177/0091270005283282 SAGE Publications <![CDATA[Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs]]> http://www.jcp.sagepub.com/cgi/content/short/47/5/566?rss=1&ssource=mfc May 1, 2007; 47:566-578
]]> Bradley L. Urquhart, Rommel G. Tirona, Richard B. Kim 2007-05-01 10.1177/0091270007299930 SAGE Publications <![CDATA[Evaluation of Population Pharmacokinetics and Exposure-Response Relationship With Coadministration of Amlodipine Besylate and Olmesartan Medoxomil]]> http://www.jcp.sagepub.com/cgi/content/short/48/7/823?rss=1&ssource=mfc Jul 1, 2008; 48:823-836
Quantitative Clinical Pharmacology]]> Shashank Rohatagi, Timothy J. Carrothers, Smita Kshirsagar, Tatiana Khariton, James Lee, Daniel Salazar 2008-07-01 SAGE Publications <![CDATA[Globalization of Quantitative Pharmacology: First International Symposium of Quantitative Pharmacology in Drug Development and Regulation]]> http://www.jcp.sagepub.com/cgi/content/short/48/7/787?rss=1&ssource=mfc Jul 1, 2008; 48:787-792
Annual Meetings and Symposia]]> Jeffrey S. Barrett, Jun Shi, Hai-tang Xie, Xiao-hui Huang, Michael J. Fossler, Rui-yuan Sun 2008-07-01 SAGE Publications <![CDATA[The Impact of Suppressing the Renin-Angiotensin System on Atrial Fibrillation]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/21?rss=1&ssource=mfc Jan 1, 2006; 46:21-28
Clinical Studies]]> James S. Kalus, Craig I. Coleman, C. Michael White 2006-01-01 10.1177/0091270005283284 SAGE Publications <![CDATA[Effects of Aliskiren, a Direct Renin Inhibitor, on Cardiac Repolarization and Conduction in Healthy Subjects]]> http://www.jcp.sagepub.com/cgi/content/short/48/7/799?rss=1&ssource=mfc Jul 1, 2008; 48:799-811
Pharmacokinetics and Pharmacodynamics]]> Surya Ayalasomayajula, Ching-Ming Yeh, Sujata Vaidyanathan, Brian Flannery, Hans Armin Dieterich, Dan Howard, Martin P. Bedigian, William P. Dole 2008-07-01 SAGE Publications <![CDATA[Challenges and Opportunities for Pharmacoepidemiology in Drug-Therapy Decision Making]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/6?rss=1&ssource=mfc Jan 1, 2006; 46:6-9
Forum]]> Mahyar Etminan, Sudeep Gill, Mark FitzGerald, Ali Samii 2006-01-01 10.1177/0091270005283285 SAGE Publications <![CDATA[Population Pharmacokinetics and Pharmacodynamics of Meropenem in Pediatric Patients]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/69?rss=1&ssource=mfc Jan 1, 2006; 46:69-75
Pharmacokinetics and Pharmacodynamics]]> Xiaoli Du, Chonghua Li, Joseph L. Kuti, Charles H. Nightingale, David P. Nicolau 2006-01-01 10.1177/0091270005283283 SAGE Publications <![CDATA[The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/88?rss=1&ssource=mfc Jan 1, 2006; 46:88-102
Pharmacokinetics and Pharmacodynamics]]> Reza Khosravan, Brian A. Grabowski, Michael D. Mayer, Jing-Tao Wu, Nancy Joseph-Ridge, Laurent Vernillet 2006-01-01 10.1177/0091270005282634 SAGE Publications <![CDATA[Novel Trial Design: A Report From the 19th Frontiers Symposium of ACCP]]> http://www.jcp.sagepub.com/cgi/content/short/48/7/793?rss=1&ssource=mfc Jul 1, 2008; 48:793-798
Annual Meetings and Symposia]]> Barbara Ameer 2008-07-01 SAGE Publications <![CDATA[An Improved Approach for Confirmatory Phase III Population Pharmacokinetic Analysis]]> http://www.jcp.sagepub.com/cgi/content/short/48/7/812?rss=1&ssource=mfc Jul 1, 2008; 48:812-822
Quantitative Clinical Pharmacology]]> Chuanpu Hu, Honghui Zhou 2008-07-01 SAGE Publications <![CDATA[Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development]]> http://www.jcp.sagepub.com/cgi/content/short/47/5/553?rss=1&ssource=mfc May 1, 2007; 47:553-565
Biologics]]> Mary Ann Mascelli, Honghui Zhou, Raymond Sweet, Jay Getsy, Hugh M. Davis, Martin Graham, Darrell Abernethy 2007-05-01 SAGE Publications <![CDATA[Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings]]> http://www.jcp.sagepub.com/cgi/content/short/48/5/632?rss=1&ssource=mfc May 1, 2008; 48:632-649
Forum]]> Jeffrey S. Barrett, Michael J. Fossler, K. David Cadieu, Marc R. Gastonguay 2008-05-01 10.1177/0091270008315318 SAGE Publications <![CDATA[P-glycoprotein: So Many Ways to Turn It On]]> http://www.jcp.sagepub.com/cgi/content/short/48/3/365?rss=1&ssource=mfc Mar 1, 2008; 48:365-378
Review/Drug Metabolism Transport]]> Richard Callaghan, Emily Crowley, Simon Potter, Ian D. Kerr 2008-03-01 SAGE Publications <![CDATA[A Single-Dose Pharmacokinetic Study of Lasofoxifene in Healthy Volunteers and Subjects With Mild and Moderate Hepatic Impairment]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/29?rss=1&ssource=mfc Jan 1, 2006; 46:29-36
Pharmacokinetics]]> Candace Bramson, Daniele Ouellet, Doina Roman, Edward Randinitis, Mark J. Gardner 2006-01-01 10.1177/0091270005283278 SAGE Publications <![CDATA[Pharmacokinetic Drug-Drug Interaction Potentials for Therapeutic Monoclonal Antibodies: Reality Check]]> http://www.jcp.sagepub.com/cgi/content/short/47/9/1104?rss=1&ssource=mfc Sep 1, 2007; 47:1104-1118
Biologics]]> Kathleen Seitz, Honghui Zhou 2007-09-01 10.1177/0091270007306958 SAGE Publications <![CDATA[A Comparative Study of Sirolimus Tablet Versus Oral Solution for Prophylaxis of Acute Renal Allograft Rejection]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/76?rss=1&ssource=mfc Jan 1, 2006; 46:76-87
Pharmacokinetics and Pharmacodynamics]]> Timothy H. Mathew, Charles Van Buren, Barry D. Kahan, Khalid Butt, Sundaram Hariharan, James J. Zimmerman, for the Rapamune 309 Study Group 2006-01-01 10.1177/0091270005282628 SAGE Publications <![CDATA[Effect of High-Dose Aspirin on CYP2E1 Activity in Healthy Subjects Measured Using Chlorzoxazone as a Probe]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/109?rss=1&ssource=mfc Jan 1, 2006; 46:109-114
Drug Interactions]]> Ji-Young Park, Kyoung-Ah Kim, Pil-Whan Park, Jong-Myung Ha 2006-01-01 10.1177/0091270005282635 SAGE Publications <![CDATA[Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, in Healthy Male Volunteers]]> http://www.jcp.sagepub.com/cgi/content/short/48/6/734?rss=1&ssource=mfc Jun 1, 2008; 48:734-744
Pharmacokinetics and Pharmacodynamics]]> Carol Addy, Paul Rothenberg, Susie Li, Anup Majumdar, Nancy Agrawal, Hankun Li, Ling Zhong, Jinyu Yuan, Andrea Maes, Stephanie Dunbar, Josee Cote, Kim Rosko, Kristien Van Dyck, Inge De Lepeleire, Jan de Hoon, Anne Van Hecken, Marleen Depre, Annemie Knops, Keith Gottesdiener, Aubrey Stoch, John Wagner 2008-06-01 10.1177/0091270008317591 SAGE Publications <![CDATA[Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan]]> http://www.jcp.sagepub.com/cgi/content/short/48/8/900?rss=1&ssource=mfc Aug 1, 2008; 48:900-908
Forum/Regulatory Science]]> Henry J. Malinowski, Agnes Westelinck, Junko Sato, Ting Ong 2008-08-01 SAGE Publications <![CDATA[Pharmacokinetics of Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Male Subjects: Pharmacokinetic Model Development for Phase 2/3 Simulation of Exposure]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/37?rss=1&ssource=mfc Jan 1, 2006; 46:37-44
Pharmacokinetics]]> Anne Paccaly, Annke Frick, Shashank Rohatagi, Jingli Liu, Umesh Shukla, Ronald Rosenburg, Markus Hinder, Bradford K. Jensen 2006-01-01 10.1177/0091270005281817 SAGE Publications <![CDATA[Reducing Medication Errors and Increasing Patient Safety: Case Studies in Clinical Pharmacology]]> http://www.jcp.sagepub.com/cgi/content/short/43/7/768?rss=1&ssource=mfc Jul 1, 2003; 43:768-783
Symposium]]> David M. Benjamin 2003-07-01 10.1177/0091270003254794 SAGE Publications <![CDATA[Pharmacokinetics and Safety of Golimumab, a Fully Human Anti-TNF-{alpha} Monoclonal Antibody, in Subjects With Rheumatoid Arthritis]]> http://www.jcp.sagepub.com/cgi/content/short/47/3/383?rss=1&ssource=mfc Mar 1, 2007; 47:383-396
Biologics]]> Honghui Zhou, Haishan Jang, Roy M. Fleischmann, Esther Bouman-Thio, Zhenhua Xu, Joseph C. Marini, Charles Pendley, Qun Jiao, Gopi Shankar, Stanley J. Marciniak, Stanley B. Cohen, Mahboob U. Rahman, Daniel Baker, Mary Ann Mascelli, Hugh M. Davis, Daniel E. Everitt 2007-03-01 10.1177/0091270006298188 SAGE Publications <![CDATA[Population Pharmacokinetic Modeling of Epoetin Delta in Pediatric Patients With Chronic Kidney Disease]]> http://www.jcp.sagepub.com/cgi/content/short/48/7/837?rss=1&ssource=mfc Jul 1, 2008; 48:837-848
Quantitative Clinical Pharmacology]]> William Knebel, Mary Palmen, James A. Dowell, Marc Gastonguay 2008-07-01 SAGE Publications <![CDATA[The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective]]> http://www.jcp.sagepub.com/cgi/content/short/43/5/443?rss=1&ssource=mfc May 1, 2003; 43:443-469
Drug Development]]> Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, Scott R. Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh, Steven A. Wrighton 2003-05-01 10.1177/0091270003252519 SAGE Publications <![CDATA[The Effect of Oral Pleconaril on Hepatic Cytochrome P450 3A Activity in Healthy Adults Using Intravenous Midazolam as a Probe]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/103?rss=1&ssource=mfc Jan 1, 2006; 46:103-108
Drug Metabolism]]> Joseph D. Ma, Anne N. Nafziger, Gerry Rhodes, Siyu Liu, Anne M. Gartung, Joseph S. Bertino Jr 2006-01-01 10.1177/0091270005283286 SAGE Publications <![CDATA[Nebivolol: Pharmacologic Profile of an Ultraselective, Vasodilatory {beta}1-Blocker]]> http://www.jcp.sagepub.com/cgi/content/short/48/2/225?rss=1&ssource=mfc Feb 1, 2008; 48:225-239
Therapeutic Review]]> L. Michael Prisant 2008-02-01 SAGE Publications <![CDATA[Population Pharmacokinetic and Pharmacodynamic Analysis of a Class IC Antiarrhythmic, Pilsicainide, in Patients With Cardiac Arrhythmias]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/59?rss=1&ssource=mfc Jan 1, 2006; 46:59-68
Pharmacokinetics and Pharmacodynamics]]> Ryuichi Ogawa, Ryoji Kishi, Kiyoshi Mihara, Harumi Takahashi, Akihiko Takagi, Naoki Matsumoto, Keisou Masuhara, Kiyoshi Nakazawa, Fumihiko Miyake, Shinichi Kobayashi, Hirotoshi Echizen 2006-01-01 10.1177/0091270005283281 SAGE Publications <![CDATA[A Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial]]> http://www.jcp.sagepub.com/cgi/content/short/47/12/1555?rss=1&ssource=mfc Dec 1, 2007; 47:1555-1569
]]> Richard A. Preston, Peter Harvey, Ottmar Herfert, Gary Dykstra, J. Wouter Jukema, Franklin Sun, David Gillen 2007-12-01 10.1177/0091270007307879 SAGE Publications <![CDATA[Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel]]> http://www.jcp.sagepub.com/cgi/content/short/48/4/475?rss=1&ssource=mfc Apr 1, 2008; 48:475-484
Drug Interactions]]> David S. Small, Nagy A. Farid, Christopher D. Payne, Govinda J. Weerakkody, Ying G. Li, John T. Brandt, Daniel E. Salazar, Kenneth J. Winters 2008-04-01 SAGE Publications <![CDATA[A Lesson in Moderation: Applying Pharmacodynamics to Clarify the Relationship Between Thiazolidinediones and Adverse Vascular Outcomes in Type 2 Diabetes]]> http://www.jcp.sagepub.com/cgi/content/short/48/8/999?rss=1&ssource=mfc Aug 1, 2008; 48:999-1002
Letter to the Editor]]> David F. Lehmann, Braj B. Lohray 2008-08-01 10.1177/0091270008319791 SAGE Publications <![CDATA[Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6]]> http://www.jcp.sagepub.com/cgi/content/short/46/12/1426?rss=1&ssource=mfc Dec 1, 2006; 46:1426-1438
Drug Metabolism]]> Robert L. Walsky, Angela V. Astuccio, R. Scott Obach 2006-12-01 10.1177/0091270006293753 SAGE Publications <![CDATA[Pharmacokinetic/Pharmacodynamic Relationships for Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Subjects]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/45?rss=1&ssource=mfc Jan 1, 2006; 46:45-51
Pharmacokinetics and Pharmacodynamics]]> Anne Paccaly, Annke Frick, Marie-Laure Ozoux, Valeria Chu, Ronald Rosenburg, Markus Hinder, Umesh Shukla, Bradford K. Jensen 2006-01-01 10.1177/0091270005281818 SAGE Publications <![CDATA[Interaction of Warfarin With Drugs, Natural Substances, and Foods]]> http://www.jcp.sagepub.com/cgi/content/short/45/2/127?rss=1&ssource=mfc Feb 1, 2005; 45:127-132
Therapeutic Review]]> David J. Greenblatt, Lisa L. von Moltke 2005-02-01 10.1177/0091270004271404 SAGE Publications <![CDATA[Drug Interaction Studies of Therapeutic Proteins or Monoclonal Antibodies]]> http://www.jcp.sagepub.com/cgi/content/short/47/12/1540?rss=1&ssource=mfc Dec 1, 2007; 47:1540-1554
Drug Interactions]]> Iftekhar Mahmood, Martin David Green 2007-12-01 SAGE Publications <![CDATA[Clinical Pharmacology of Multiple Doses of Lasofoxifene in Postmenopausal Women]]> http://www.jcp.sagepub.com/cgi/content/short/46/1/52?rss=1&ssource=mfc Jan 1, 2006; 46:52-58
Pharmacokinetics and Pharmacodynamics]]> Mark Gardner, Ann Taylor, Greg Wei, Albert Calcagni Jr, Barbara Duncan, Ashley Milton 2006-01-01 10.1177/0091270005283280 SAGE Publications <![CDATA[Pharmacokinetic Strategies in Deciphering Atypical Drug Absorption Profiles]]> http://www.jcp.sagepub.com/cgi/content/short/43/3/211?rss=1&ssource=mfc Mar 1, 2003; 43:211-227
Drug Development]]> Honghui Zhou 2003-03-01 10.1177/0091270002250613 SAGE Publications <![CDATA[Prevalence of Platelet Nonresponsiveness to Aspirin in Patients Treated for Secondary Stroke Prophylaxis and in Patients With Recurrent Ischemic Events]]> http://www.jcp.sagepub.com/cgi/content/short/48/3/335?rss=1&ssource=mfc Mar 1, 2008; 48:335-343
Clinical Studies]]> Francis M. Gengo, Michelle Rainka, Matthew Robson, Michael F. Gengo, Alan Forrest, Maurice Hourihane, Vernice Bates 2008-03-01 SAGE Publications <![CDATA[Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan]]> http://www.jcp.sagepub.com/cgi/content/short/0091270008319794v1?rss=1&ssource=mfc Aug 1, 2008; 48:900-908
Forum/Regulatory Science]]> Henry J. Malinowski, Agnes Westelinck, Junko Sato, Ting Ong 2008-08-01 SAGE Publications <![CDATA[Concentration-QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review]]> http://www.jcp.sagepub.com/cgi/content/short/48/1/13?rss=1&ssource=mfc Jan 1, 2008; 48:13-18
Regulatory Science]]> Christine E. Garnett, Nhi Beasley, V. Atul Bhattaram, Pravin R. Jadhav, Rajanikanth Madabushi, Norman Stockbridge, Christoffer W. Tornoe, Yaning Wang, Hao Zhu, Jogarao V. Gobburu 2008-01-01 10.1177/0091270007307881 SAGE Publications <![CDATA[Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis]]> http://www.jcp.sagepub.com/cgi/content/short/48/4/406?rss=1&ssource=mfc Apr 1, 2008; 48:406-417
Biologics]]> Ivan Nestorov, Alain Munafo, Orestis Papasouliotis, Jennifer Visich 2008-04-01 SAGE Publications <![CDATA[Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, for the Treatment of Obesity: Results From a Double-Blind, Placebo-Controlled, Single Oral Dose Study in Healthy Volunteers]]> http://www.jcp.sagepub.com/cgi/content/short/48/4/418?rss=1&ssource=mfc Apr 1, 2008; 48:418-427
Pharmacokinetics and Pharmacodynamics]]> Carol Addy, Susie Li, Nancy Agrawal, Julie Stone, Anup Majumdar, Ling Zhong, Hankun Li, Jinyu Yuan, Andrea Maes, Paul Rothenberg, Josee Cote, Kim Rosko, Corinne Cummings, Steven Warrington, Malcolm Boyce, Keith Gottesdiener, Aubrey Stoch, John Wagner 2008-04-01 SAGE Publications <![CDATA[Pharmacodynamics of Vildagliptin in Patients With Type 2 Diabetes During OGTT]]> http://www.jcp.sagepub.com/cgi/content/short/47/5/633?rss=1&ssource=mfc May 1, 2007; 47:633-641
Pharmacokinetics and Pharmacodynamics]]> Yan-Ling He, Yibin Wang, Julie M. Bullock, Carolyn F. Deacon, Jens Juul Holst, Beth E. Dunning, Monica Ligueros-Saylan, James E. Foley 2007-05-01 10.1177/0091270006299137 SAGE Publications <![CDATA[Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval]]> http://www.jcp.sagepub.com/cgi/content/short/48/6/726?rss=1&ssource=mfc Jun 1, 2008; 48:726-733
Quantitative Clinical Pharmacology]]> M. Iwamoto, J. T. Kost, G. C. Mistry, L. A. Wenning, S. A. Breidinger, T. C. Marbury, J. A. Stone, K. M. Gottesdiener, D. M. Bloomfield, J. A. Wagner 2008-06-01 SAGE Publications <![CDATA[Effects of the Oral, Direct Factor Xa Inhibitor Rivaroxaban on Platelet-Induced Thrombin Generation and Prothrombinase Activity]]> http://www.jcp.sagepub.com/cgi/content/short/47/11/1398?rss=1&ssource=mfc Nov 1, 2007; 47:1398-1407
Pharmacodynamics]]> Jochen Graff, Nils von Hentig, Frank Misselwitz, Dagmar Kubitza, Michael Becka, Hans-Klaus Breddin, Sebastian Harder 2007-11-01 SAGE Publications <![CDATA[Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Rivaroxaban--an Oral, Direct Factor Xa Inhibitor--Are Not Affected by Aspirin]]> http://www.jcp.sagepub.com/cgi/content/short/46/9/981?rss=1&ssource=mfc Sep 1, 2006; 46:981-990
Pharmacokinetics and Pharmacodynamics]]> Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Michael Zuehlsdorf 2006-09-01 10.1177/0091270006292127 SAGE Publications <![CDATA[Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension]]> http://www.jcp.sagepub.com/cgi/content/short/48/5/592?rss=1&ssource=mfc May 1, 2008; 48:592-598
Pharmacokinetics and Pharmacodynamics]]> Goutam C. Mistry, Andrea L. Maes, Kenneth C. Lasseter, Michael J. Davies, Keith M. Gottesdiener, John A. Wagner, Gary A. Herman 2008-05-01 SAGE Publications